USADA announced today that Eliud Ngetich, of El Doret, Kenya, an athlete in the sport of track and field, has accepted a two-year period of ineligibility for an anti-doping rule violation committed under the 2009 version of the World Anti-Doping Code. Ngetich, 27, tested positive for nandrolone, also known as 19-nortestosterone.

The results of isotope ratio mass spectrometry (IRMS) were consistent with exogenous origin of 19-norandrosterone (19-NA), a metabolite of nandrolone, in an out-of-competition urine sample collected on December 6, 2014. Nandrolone and 19-NA are Non-Specified Substances in the class of Anabolic Agents and prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the International Association of Athletics Federations (now World Athletics) Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.

After considering the case, USADA suspended one year of the two-year sanction due to the substantial assistance that Ngetich provided, which is the reason for the delay in announcing Ngetich’s sanction. Ngetich served a four-month provisional suspension from March 28, 2015 to July 27, 2015, and his remaining eight-month period of ineligibility began on August 19, 2021, the date he accepted this sanction. In addition, Ngetich has been disqualified from competitive results obtained on July 1, 2014 through July 27, 2015, the end of his provisional suspension, including forfeiture of any medals, points and prizes.

• This media release was published by the US Anti-Doping Agency (USADA) on 3 September 2021. Click here for the original.